AVM Biotechnology

AVM Biotechnology

AVM Biotechnology

AVM Biotechnology is engaged in the R&D of ethical stem cell technologies forregenerative medicine, oncology, and fully-human biologics.
Type
B2c
Founded
2008
Raised
$21.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$2,840,000
Venture capital - 2016
$17,500,000
Undisclosed funding - 2016
Team Size
2
Employees
$17,500,000 Undisclosed funding
GeekWire

AVM Biotechnology raising $17.5M to improve safety and delivery of stem cells

Science